NO852576L - Dihydropyridinderivater. - Google Patents

Dihydropyridinderivater.

Info

Publication number
NO852576L
NO852576L NO852576A NO852576A NO852576L NO 852576 L NO852576 L NO 852576L NO 852576 A NO852576 A NO 852576A NO 852576 A NO852576 A NO 852576A NO 852576 L NO852576 L NO 852576L
Authority
NO
Norway
Prior art keywords
alkyl
ester
nitrophenyl
dihydro
acetyl
Prior art date
Application number
NO852576A
Other languages
English (en)
Norwegian (no)
Inventor
Roland Jaunin
Henri Ramuz
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO852576L publication Critical patent/NO852576L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/021,2-Thiazines; Hydrogenated 1,2-thiazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Dental Preparations (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO852576A 1984-06-27 1985-06-26 Dihydropyridinderivater. NO852576L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH309784 1984-06-27

Publications (1)

Publication Number Publication Date
NO852576L true NO852576L (no) 1985-12-30

Family

ID=4248551

Family Applications (1)

Application Number Title Priority Date Filing Date
NO852576A NO852576L (no) 1984-06-27 1985-06-26 Dihydropyridinderivater.

Country Status (16)

Country Link
US (1) US4742069A (da)
EP (1) EP0166422A1 (da)
JP (1) JPS6118762A (da)
CN (1) CN85105335A (da)
AU (1) AU4399185A (da)
DK (1) DK288085A (da)
ES (2) ES8609253A1 (da)
FI (1) FI852359L (da)
GR (1) GR851554B (da)
HU (1) HU193784B (da)
IL (1) IL75595A0 (da)
MC (1) MC1675A1 (da)
NO (1) NO852576L (da)
PH (1) PH21510A (da)
PT (1) PT80719B (da)
ZA (1) ZA854665B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6541479B1 (en) * 1997-12-02 2003-04-01 Massachusetts College Of Pharmacy Calcium channel blockers
CN106011652B (zh) 2016-06-28 2017-12-26 宝山钢铁股份有限公司 一种磷化性能优异的冷轧低密度钢板及其制造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2639498A1 (de) * 1976-09-02 1978-03-09 Bayer Ag Neue schwefelhaltige amino-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2658183A1 (de) * 1976-12-22 1978-07-06 Bayer Ag In 2-position substituierte 1,4- dihydropyridin-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2747513A1 (de) * 1977-10-22 1979-05-03 Bayer Ag Dihydropyridine mit schwefelhaltigen estergruppierungen
SE429652B (sv) * 1978-06-30 1983-09-19 Haessle Ab 2.6-dimetyl-4-(2.3-diklorfenyl)-1.4-dihydropyridin-3.5-dikarboxylsyra-3-metylester-5-etylester
DE3116129A1 (de) * 1981-04-23 1982-11-11 Hoechst Ag, 6000 Frankfurt 2-ketosulfonamide und verfahren zu ihrer herstellung
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines

Also Published As

Publication number Publication date
IL75595A0 (en) 1985-10-31
PT80719A (en) 1985-07-01
DK288085D0 (da) 1985-06-25
FI852359L (fi) 1985-12-28
ZA854665B (en) 1986-02-26
FI852359A0 (fi) 1985-06-13
HU193784B (en) 1987-11-30
HUT37923A (en) 1986-03-28
ES8609253A1 (es) 1986-09-01
AU4399185A (en) 1986-01-02
PT80719B (en) 1987-04-23
ES8705388A1 (es) 1987-05-01
MC1675A1 (fr) 1986-06-03
US4742069A (en) 1988-05-03
DK288085A (da) 1985-12-28
PH21510A (en) 1987-11-10
CN85105335A (zh) 1987-01-14
GR851554B (da) 1985-11-25
JPS6118762A (ja) 1986-01-27
ES551817A0 (es) 1987-05-01
ES544558A0 (es) 1986-09-01
EP0166422A1 (de) 1986-01-02

Similar Documents

Publication Publication Date Title
AU2004238521B2 (en) Isoquinoline derivatives and their use as GFAT inhibitors
US7776889B2 (en) Spirocyclic thrombin receptor antagonists
US7799779B2 (en) Substituted piperidines as renin inhibitors
EP0906310A1 (en) OXADIAZOLE BENZENESULFONAMIDES AS SELECTIVE $g(b) 3? AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY
DK164158B (da) 1,4-dihydropyridincarboxylsyreestere
EP1725231A1 (en) Triazole, oxadiazole and thiadiazole derivatives as ppar modulators for the treatment of diabetes
EP2075250A2 (en) Thrombin receptor antagonists
FR2967674A1 (fr) Derives d'heteroarylsulfonamides, leur preparation et leur application en therapeutique humaine
US6011048A (en) Thiazole benzenesulfonamides as β3 agonists for treatment of diabetes and obesity
NO312100B1 (no) Nytt tiazolidindion-2-derivat, fremgangsmåter for dets fremstilling, mellomproduktforbindelser, samt farmasöytiskepreparater som inneholder det
JPH0631224B2 (ja) ジヒドロピリジンカルボキシアミド類
KR960012206B1 (ko) 티아졸리딘-2,4-디온 유도체 및 이의 염, 이의 제조방법 및 이의 용도
FI83773B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 1,4-dihydropyridinderivat.
HU221811B1 (hu) N-acilezett-piperidin-származékok, eljárás ezek előállítására, és ezeket tartalmazó gyógyászati készítmények
EP3145935A1 (en) Pharmaceutically active compounds as dag-lipase inhibitors
BRPI0715412A2 (pt) nitrato de Ésferes de piperidina
US6034106A (en) Oxadiazole benzenesulfonamides as selective β3 Agonist for the treatment of Diabetes and Obesity
US4458075A (en) 6-Fluoro-3-[3-(1-heterocyclo)propyl]-1,2-benzisoxazoles
NO852576L (no) Dihydropyridinderivater.
US4876255A (en) Substituted 1,4-dihydropyridines for control of circulation and thromboses
US4994612A (en) Ylidene sulfonamide derivatives
NO142403B (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive isokinoliner
US4598152A (en) 6-fluoro-3-[3-(oxoheterocyclo)propyl]-1,2-benzisoxazoles
US4524209A (en) 6-Fluoro-3-[3-(1-heterocyclo)propyl]-1,2-benzisoxazoles
US4591586A (en) 6-fluoro-3-[3-(1-heterocyclo)propyl]-1,2-benzisoxazoles for treatment of pain, hypertension and psychoses